Skip to main content
×
Home
    • Aa
    • Aa

Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay

  • Serafim Kiriakidis (a1), Oliver Högemeier (a2), Susanne Starcke (a1), Frank Dombrowski (a2), Jens Claus Hahne (a2), Michael Pepper (a3), Hem Chandra Jha (a1) and Nicolas Wernert (a2)...
Abstract

Anti-angiogenic strategies are emerging as an important tool for the treatment of cancer and inflammatory diseases. In the present investigation we isolated several isoflavones from a tempeh (fermented soyabean) extract. The isolated isoflavones were identified as 5,7,4′-trihydroxyisoflavone (genistein), 7,4′-dihydroxyisoflavone (daidzein), 6,7,4′-trihydroxyisoflavone (factor 2), 7,8,4′-trihydroxyisoflavone (7,8,4′-TriOH) and 5,7,3′,4′-tetrahydroxyisoflavone (orobol). The effects on angiogenesis of these isoflavones were evaluated in the chicken chorioallantoic membrane assay; their capacity to inhibit vascular endothelial growth factor-induced endothelial cell proliferation and expression of the Ets 1 transcription factor, known to be implicated in the regulation of new blood vessel formation, were also investigated. We found that all isoflavones inhibited angiogenesis, albeit with different potencies. Compared with negative controls, which slightly inhibited in vivo angiogenesis by 6·30 %, genistein reduced angiogensis by 75·09 %, followed by orobol (67·96 %), factor 2 (56·77 %), daidzein (48·98 %) and 7,8,4′-TriOH (24·42 %). These compounds also inhibited endothelial cell proliferation, with orobol causing the greatest inhibition at lower concentrations. The isoflavones also inhibited Ets 1 expression, providing some insight into the molecular mechanisms of their action. Furthermore, the chemical structure of the different isoflavones suggests a structure–activity relationship. Our present findings suggest that the new isoflavones might be added to the list of low molecular mass therapeutic agents for the inhibition of angiogenesis.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr Serafim Kiriakidis, fax +44 20 8383 4499, email s.kiriakidis@imperial.ac.uk
References
Hide All
Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M & Fukami Y (1987) Genistein, a specific inhibitor of tyrosine specific protein kinases. J Biol Chem 262, 55925595.
Auerbach R, Lewis R, Shinners B, Kubai L & Akhtar N (2003) Angiogenesis assays: a critical overview. Clin Chem 49, 3240.
Belotti D & Castronovo V (1998) Tumor angiogenesis: basis for new prognostic factors and new anticancer therapies. In Clinical and Biological Basis for Lung Cancer Prevention, pp. 95103 [Martinet Y, editors]. Basel: Birkhaeuser.
Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD & Thorpe PE (2000) Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res 60, 51175124.
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G & Cheresh DA (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 11571164.
Carmeliet P & Collen D (2000) Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol 190, 387405.
Carmeliet P & Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407, 249257.
Chen CT, Lin J & Li Q (2000) Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin. Hum Gene Ther 11, 19831996.
De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N & Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989991.
Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M & Scjlessinger J (1990) Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9, 26852692.
Drixler TA, Rinkes IH, Ritchie ED, van Vroonhoven TJ, Gebbink MF & Voest EE (2000) Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 60, 17611765.
Feldman AL, Restifo NP, Alexander HR, Bartlett DL, Hwu P, Seth P & Libutti SK (2000) Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. Cancer Res 60, 15031506.
Fisher RJ, Koizumi S, Kondoh A, Marino JM, Mavrothalassitis G, Bhat NK & Papas TS (1992) Human Ets1 oncoprotein purification, isoforms, SH modification, and DNA sequence specific binding. J Biol Chem 267, 1795717965.
Fleischman LF, Holtzclaw L, Russell JT, Mavrothalassitis G & Fisher RJ (1995) ets-1 in astrocytes: expression and transmitter-evoked phosphorylation. Mol Cell Biol 15, 925993.
Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid, and other diseases. Nat Med 1, 2731.
Fotsis T (1995) Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125, 790S797S.
Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wähälä K, Montesano R & Schweigerer L (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57, 29162921.
György P, Murata K & Ikehata H (1964) Antioxidants isolated from fermented soybeans (Tempe). Nature 203, 870872.
Huang C, Papas TS & Bhat NK (1997) A variant form of Ets1 induces apoptosis in human colon cancer cells. Oncogene 15, 851856.
Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H & Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348, 555557.
Iwasaka C, Tanaka K, Abe M & Sato Y (1996) Ets 1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169, 522531.
Jorcyk CL, K WD, Mavrothalassitis GJ & Papas TS (1991) The human Ets1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene 6, 523532.
Kerbel RS (1997) A cancer therapy resistant to resistance. Nature 390, 335336.
Kilpatrick LM, Kola I & Salamonsen LA (1999) Transcription factors Ets1, Ets2, and Elf1 exhibit differential localization in human endometrium across the menstrual cycle and alternate isoforms in cultured endometrial cells. Biol Reprod 61, 120126.
Klus K & Barz W (1995) Formation of polyhydroxylated isoflavones from the soybean seed isoflavones daidzein and glycitein by bacteria isolated from tempe. Arch Microbiol 164, 428434.
Li R, Pei H & Papas T (1999) The p42 variant of ETS1 protein rescues defective Fas-induced apoptosis in colon carcinoma cells. Proc Natl Acad Sci USA 96, 38763881.
Pepper MS (2000) Angiogénèse et morphogenèse de l'arbre vasculaire: de la biologie cellulaire à la clinique (Angiogenesis and morphogenesis of the vascular tree: From cell biology to the clinic). Médecine/Science 16, 13781386.
Pepper MS (2001) Extracellular proteolysis and angiogenesis. Thromb Haemost 86, 346355.
Pfeifer A, Kessler T, Silletti S, Cheresh DA & Verma IM (2000) Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc Natl Acad Sci USA 97, 1222712232.
Sarkar FH & Li Y (2003) Soy isoflavones and cancer prevention. Cancer Invest 21, 744757.
Shiose S, Sakamoto T, Yoshikawa H, Hata Y, Kawano Y, Ishibashi T, Inomata H, Takayama K & Ueno H (2000) Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma. Invest Ophthalmol Vis Sci 41, 23952403.
Takayama K, Ueno H, Nakanishi Y, Sakamoto T, Inoue K, Shimizu K, Oohashi H & Hara N (2000) Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res 60, 21692177.
Vajkoczy P, Thurnher A, Hirth KP, Schilling L, Schmiedek P, Ullrich A & Menger MD (2000) Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications. Oncologist 5 Suppl. 1 1619.
Valter M, Hugel A, Huang HJ, Cavenee WK, Wiestler OD, Pietsch T & Wernert N (1999) Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59, 56085614.
Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA, Stéhelin D (1989) Complementary patterns of expression of c- ets 1, c- myb and c- myc in the blood forming system of the chick embryo. Development 107, 265274.
Vitaliti A, Wittmer M, Steiner R, Wyder L, Neri D & Klemenz R (2000) Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor. Cancer Res 60, 43114314.
Wernert N (1997) The multiple roles of tumour stroma. Virch Arch 430, 433443.
Wernert N, Justen HP, Rothe M, Behrens P, Dreschers S, Neuhaus T, Florin A, Sachinidis A, Vetter H & Ko Y (2002) The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis. J Mol Med 80, 258266.
Wernert N, Raes MB, Lasalle P, Gosselin B, Vandenbunder B, Stéhelin D (1992) The c- ets 1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in man. Am J Pathol 140, 119127.
Wernert N, Stanjek A, Kiriakidis S, Hügel A, Jha HC, Mazitschek R & Giannis A (1999) Inhibition of angiogenesis in vivo by ets-1 antisense oligonucleotides – inhibition of Ets-1 transcription factor expression by the antibiotic Fumagillin. Angew Chem Int Ed Engl 38, 32283231.
Yancopoulos GD, Davies S, Gale NW, Rudge JS, Wiegand SJ & Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407, 242247.
Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T & Kuroiwa Y (1999) Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 64, 249258.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 86 *
Loading metrics...

Abstract views

Total abstract views: 201 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 24th October 2017. This data will be updated every 24 hours.